| 000 | 01518 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512055750.0 | ||
| 264 | 0 | _c19860916 | |
| 008 | 198609s 0 0 eng d | ||
| 022 | _a0312-5963 | ||
| 024 | 7 |
_a10.2165/00003088-198611030-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbernethy, D R | |
| 245 | 0 | 0 |
_aDrug disposition in obese humans. An update. _h[electronic resource] |
| 260 |
_bClinical pharmacokinetics _c |
||
| 300 |
_a199-213 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAminoglycosides _xmetabolism |
| 650 | 0 | 4 |
_aAnalgesics _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xmetabolism |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xmetabolism |
| 650 | 0 | 4 |
_aBenzodiazepines _xmetabolism |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aCimetidine _xmetabolism |
| 650 | 0 | 4 |
_aDigoxin _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aObesity _xmetabolism |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xblood |
| 650 | 0 | 4 |
_aPhenytoin _xmetabolism |
| 650 | 0 | 4 |
_aPrednisolone _xmetabolism |
| 650 | 0 | 4 |
_aThiopental _xmetabolism |
| 650 | 0 | 4 |
_aVerapamil _xmetabolism |
| 650 | 0 | 4 |
_aXanthines _xmetabolism |
| 700 | 1 | _aGreenblatt, D J | |
| 773 | 0 |
_tClinical pharmacokinetics _gvol. 11 _gno. 3 _gp. 199-213 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003088-198611030-00002 _zAvailable from publisher's website |
| 999 |
_c3530677 _d3530677 |
||